Logo - springer
Slogan - springer

Medicine - Orthopedics | Osteoporosis International - incl. option to publish open access (Press)

Osteoporosis International

Osteoporosis International

With other metabolic bone diseases

Co-Editors-in-Chief: J. Kanis; F. Cosman

ISSN: 0937-941X (print version)
ISSN: 1433-2965 (electronic version)

Journal no. 198

$199.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 12 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

CME and Concise Clinical Reviews


The International Osteoporosis Foundation (IOF) and National Osteoporosis Foundation (NOF) strive to present evidence-based information to physicians, researchers and other healthcare professionals in order to improve the prevention, diagnosis and clinical management of osteoporosis and associated fractures. Medical practice is informed by a thorough knowledge of scientific methods. A thorough knowledge and understanding of the current issues and developments in the field is necessary to ensure the highest standard of care for patients with osteoporosis. One means of providing that knowledge and understanding is the process of manuscript review. Review of manuscripts being considered for publication in Osteoporosis International, a joint initiative of IOF and NOF, provides a format for learning, helps reviewers to improve their skills in performing critical analysis of the medical literature, and ultimately improves the quality of the resulting publications. Credit for manuscript review is available for U.S. based physicians for reviewers from either the European or North American editorial office. This program is administered through NOF on behalf of both organizations.
The National Osteoporosis Foundation (NOF) is accredited by the Accreditation Council on Continuing Medical Education to provide continuing medical education for physicians.
NOF designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Those who serve as manuscript reviewers for Osteoporosis International may claim up to 3 AMA PRA Category 1 Credits™ per review, up to a maximum of five reviews of 15 CME credits per calendar year.
Please submit only submit one request per manuscript. Credits are based on the number of hours spent on this review. To claim credit for manuscript review, complete the information below, sign and submit to the North American Editorial Office, to the attention of Adrianne Tewksbury with your manuscript review (tewksburya@helenhayeshosp.org).
Target Audience
Clinical investigators and clinicians in endocrinology, rheumatology, orthopedics and bone metabolism and in other specialties with appropriate qualifications to perform manuscript review.
Learner Objectives
Upon completion of this CME activity, participants will be able to:
• Improve their skills in performing critical analyses of the medical literature.
• Improve their knowledge of current issues and developments in the field of endocrinology and allied sciences.
• Improve their behavior and performance in practice.
Procedure for Reviewers
1. Reviewers should follow standard procedures for manuscript review
2. To request credit, complete the form at the bottom of this page entitled 'CME Credit Request for Manuscript Review Form'
3. Submit completed form with your review to Adrianne Tewksbury in the North American Editorial Office: tewksburya@helenhayeshosp.org
4. CME certificates will be sent to the reviewer by email


The Editors are pleased to announce a new initiative for the readership of Osteoporosis International. Concise Clinical Reviews will provide brief but informative updates on common issues with clinical relevance to practicing physicians and clinical investigators. The goal of these reviews is to provide an overview of an important clinical area with key references and to provide clinical tips to assist in managing patients with osteoporosis or metabolic bone disease. The National Osteoporosis Foundation (NOF) designates this journal-based CME activity for AMA PRA Category 1 Credit for residents of the United States. For CME compliance, NOF requires authors to submit 3 learning objectives and 10 multiple choice and/or case-based learning questions with the manuscript.
Authors are encouraged to submit proposed topics to the Review Editor: E. Michael Lewiecki at mlewiecki@gmail.com

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2016 Impact Factor
  • 3.591
  • Aims and Scope

    Aims and Scope


    An international multi-disciplinary journal which is a joint initiative between the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA, Osteoporosis International provides a forum for the communication and exchange of current ideas concerning the diagnosis, prevention, treatment and management of osteoporosis and other metabolic bone diseases.

    It publishes: original papers - reporting progress and results in all areas of osteoporosis and its related fields; review articles - reflecting the present state of knowledge in special areas of summarizing limited themes in which discussion has led to clearly defined conclusions; educational articles - giving information on the progress of a topic of particular interest; case reports - of uncommon or interesting presentations of the condition.

    While focusing on clinical research, the Journal will also accept submissions on more basic aspects of research, where they are considered by the editors to be relevant to the human disease spectrum.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Authorship & Disclosure Form (doc, 50 kB...
  • CME Credit Request for Manuscript Review...
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Submission of a manuscript implies: that the work described has not been published before (except in the form of an abstract or as part of a published lecture, review, or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities at the institute where the work has been carried out; that, if and when the manuscript is accepted for publication, the authors agree to automatic transfer of the copyright to International Osteoporosis Foundation and National Osteoporosis Foundation; and that the manuscript will not be published elsewhere in any language without the consent of the copyright holders.

    All articles published in this journal are protected by copyright. The copyright covers the exclusive right and license (for U.S. government employees: to the extent transferable) to reproduce, publish, distribute and archive the article in all forms and media of expression now known or developed in the future, including reprints, translations, photographic reproductions, microform, electronic form (offline, online) or any other reproductions of similar nature. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining permission from the publisher ( Either by clicking the 'Reprints & Permissions link on the article page you are seeking permission from or contacting sean.beppler@springer.com), on behalf of the copyright holders.

    The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    An author may self-archive an author-created version of his/her article on his/her own website. He/she may also deposit this version on any repository, provided it is not made publicly available until after 12 months of official publication. He/she may not use the publisher's PDF version which is posted on link.springer.com for the purpose of self-archiving or deposit. Furthermore, the author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The original publication is available at link.springer.com".

    Please use the appropriate URL and/or DOI for the article. Articles disseminated via SpringerLink are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    The author warrants that this contribution is original and that he/she has full power to make this grant. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors.

    After submission of this agreement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer-Verlag.

    While the advice and information in this journal is believed to be true and accurate at the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein. Product Liability: The publisher can give no guarantee for information about drug dosage and application thereof contained in this journal. In every individual case the respective user must check its accuracy by consulting other pharmaceutical literature.

    Special regulations for photocopies in the USA. Photocopies may be made for personal or in-house use beyond the limitations stipulated under Section 107 or 108 of U. S. Copyright Law, provided a fee is paid. This fee is US $0.20 per page, per copy, plus a basic fee of US $2.00 per article. All fees should be paid to the Copyright Clearance Center, Inc., 21 Congress Street, Salem, MA 01970, USA, stating the ISSN number, the volume, and the first and last page numbers of each article copied. The copyright owner's consent does not include copying for general distribution, promotion, new works, or resale. In these cases specific written permission must first be obtained from the publisher (christiane.notarmarco@springer.com).

    The Canada Institute for Scientific and Technical Infomation (CISTI) provides a comprehensive, world-wide document delivery service for all Springer-Verlag journals. For more information, or to place an order for a copyright-cleared Springer-Verlag document, please contact Client Assistant, Document Delivery, Canada Institute for Scientific and Technical Information, Ottowa K1A 0S2, Canada (Tel: 613-993-9251; Fax: 613-952-8243; e-mail: cisti.docdel@nrc.ca).

    Springer-Verlag London Limited is a part of
    Springer Science+Business Media


    Ownership and copyright
    © International Osteoporosis Foundation and National Osteoporosis Foundation

Alerts for this journal


Get the table of contents of every new issue published in Osteoporosis International.